GlaxoSmithKline PLC GSK-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 09/17/21 BST
1,388.20quote price arrow down-6.80 (-0.49%)
52 week range
1,190.80 - 1,548.08
Loading...
  • Open1,403.40
  • Day High1,405.80
  • Day Low1,383.60
  • Prev Close1,395.00
  • 52 Week High1,548.08
  • 52 Week High Date09/18/20
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap96,211.7M
  • Shares Out5,031.68M
  • 10 Day Average Volume5.8M
  • Dividend80.00
  • Dividend Yield5.76%
  • Beta0.59
  • YTD % Change3.44

KEY STATS

  • Open1,403.40
  • Day High1,405.80
  • Day Low1,383.60
  • Prev Close1,395.00
  • 52 Week High1,548.08
  • 52 Week High Date09/18/20
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21
  • Market Cap96,211.7M
  • Shares Out5,031.68M
  • 10 Day Average Volume5.8M
  • Dividend80.00
  • Dividend Yield5.76%
  • Beta0.59
  • YTD % Change3.44

RATIOS/PROFITABILITY

  • EPS (TTM)87.99
  • P/E (TTM)15.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/19/2021
  • Div Amount19.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Related Video

VIDEO2:5802:58
Coronavirus antibody drugs take off

Profile

MORE
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a...
Jonathan Symonds CBE
Non-Executive Chairman
Emma Walmsley
Chief Executive Officer
Iain Mackay
Chief Financial Officer
Address
G S K House, 980 Great West Road
Brentford
TW8 9GS
United Kingdom